Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

NCT05168163 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Hepatocellular Carcinoma
Metastatic Hepatocellular Carcinoma
Stage III Hepatocellular Carcinoma AJCC v8
Stage IIIA Hepatocellular Carcinoma AJCC v8
Stage IIIB Hepatocellular Carcinoma AJCC v8
Stage IV Hepatocellular Carcinoma AJCC v8
Stage IVA Hepatocellular Carcinoma AJCC v8
Stage IVB Hepatocellular Carcinoma AJCC v8
Unresectable Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Atezolizumab
DRUG: Cabozantinib
DRUG: Lenvatinib

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]
[object Object]